June 22, 2016 Acad, Gov/Utilities Cell Analysis Tools M&A, Partnerships

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells – Cellular Dynamics International Read more

June 21, 2016 Bio/Pharma/CRO Licensing, IP, and Legal M&A, Partnerships

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more

May 31, 2016 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare joins high-profile vaccine collaboration to explore vaccine self-sufficiency and pandemic preparedness in Saudi Arabia as part of 2030 Vision

CHALFONT ST. GILES, UK AND RIYADH, SAUDI ARABIA – 31 May 2016 – GE Healthcare is entering into a vaccine collaboration with the National Industrial Clusters Development Program (NICDP) under the Ministry of Energy, Industry and Mineral Resources, SaudiVax and King Saud University, to enable vaccine self-sufficiency and pandemic preparedness in the Kingdom of Saudi... Read more

May 31, 2016 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs Beckman Coulter Sample Press Release

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs; Expands Reach for Ortho and Broadens Menu for Beckman Coulter    BREA, CA, and RARITAN, NJ, June 8, 2016 — Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics... Read more

May 18, 2016 M&A, Partnerships

GE Healthcare and The Health Management Academy Celebrate 10 Years of Advancing Healthcare Leaders Together; Renew Continued Collaboration through 2020

WAUWATOSA, WI – May 18, 2016 – GE Healthcare and The Health Management Academy (The Academy) today announced a renewed collaboration and will continue advancing healthcare by training  healthcare leaders through The Academy GE Fellows Program. Each year, 35 healthcare leaders graduate from The Academy GE Fellows Program.  This two-year comprehensive leadership development program targets high... Read more

May 13, 2016 M&A, Partnerships

GE Healthcare and Uppsala BIO form a new partnership

CHALFONT ST. GILES, UK and UPPSALA, SWEDEN – 13 May 2016 – GE Healthcare Life Sciences continues to invest in Uppsala. The company signs a two-year collaboration agreement with Uppsala BIO. The goal is to find technologies and equipment that support the production and processing of biopharmaceuticals in the future. “Although we are a large,... Read more

April 12, 2016 Bio/Pharma/CRO M&A, Partnerships

GE Healthcare expands European capabilities to support accelerated biomanufacturing

CHALFONT ST. GILES, UK and PASCHING, AUSTRIA – 12 April 2016 – GE Healthcare’s Life Sciences business today announced that its European manufacturing and distribution site for sterile liquids has expanded its capabilities to include production of large volumes of buffers, process liquids and cell culture media, and launched a rapid production service for prototype... Read more

February 29, 2016 Bio/Pharma/CRO M&A, Partnerships

JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility

WUHAN, China and AMERSHAM, England, Feb. 25, 2016 /PRNewswire/ — JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1 biopharmaceutical manufacturing facility in the Biolake area of Wuhan, China. The campus was built to be compliant with the highest international standards, and after site validation is completed in June... Read more

November 9, 2015 M&A, Partnerships

GE Healthcare Acquires Leading Healthcare Advisory Firm, The Camden Group, to enable Healthcare Organizations to Navigate Industry Transformation

BARRINGTON, Ill., November 9, 2015 — GE Healthcare (NYSE: GE) announced today it is expanding its U.S. healthcare consulting business with the acquisition of The Camden Group, one of the nation’s leading population health & strategic advisory firms. GE Healthcare Camden Group will act as the U.S. business unit of GE Healthcare’s global advisory firm,... Read more

September 7, 2015 M&A, Partnerships

Fujifilm Kyowa Kirin Biologics selects GE’s innovative MabSelect SuRe LX media for biomanufacturing process

Tokyo, Japan and Chalfont St Giles, UK – 7 September 2015 –  GE Healthcare today announced that Fujifilm Kyowa Kirin Biologics has selected GE Healthcare’s innovative MabSelect SuRe™ LX high-affinity chromatography media for the manufacture of monoclonal antibodies. http://www.genewsroom.com/press-releases/fujifilm-kyowa-kirin-biologics-selects-ge%E2%80%99s-innovative-mabselect-sure-lx-media Read more